Disruption of occludin function in polarized epithelial cells activates the extrinsic pathway of apoptosis leading to cell extrusion without loss of transepithelial resistance

BMC Cell Biology

Volumn 10, Issue , 2009, Pages

  Beeman, Neal E ^a,b   Baumgartner, Heidi K ^a   Webb, Patricia G ^a   Schaack, Jerome B ^a   Neville, Margaret C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; OCCLUDIN; CASPASE; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL POLARITY; CONTROLLED STUDY; EPITHELIUM CELL; GENE DISRUPTION; HOST PATHOGEN INTERACTION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; ANIMAL; CELL LINE; CELL MOTION; CHEMISTRY; CYTOLOGY; GENETICS; METABOLISM; PROTEIN BINDING; TIGHT JUNCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CASPASES; CELL LINE; CELL MOVEMENT; CELL POLARITY; EPITHELIAL CELLS; MEMBRANE PROTEINS; MICE; PROTEIN BINDING; RECEPTORS, DEATH DOMAIN; TIGHT JUNCTIONS;

EID: 73249135434     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-10-85     Document Type: Article

References (44)

1. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 2009, 83(4):2011-2014. 10.1128/JVI.01888-08, 2643775, 19052094.
2. Coyne CB, Shen L, Turner JR, Bergelson JM. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell host & microbe 2007, 2(3):181-192. 2719558, 18005733, 10.1016/j.chom.2007.07.003.
3. Greber UF, Gastaldelli M. Junctional gating: the achilles' heel of epithelial cells in pathogen infection. Cell host & microbe 2007, 2(3):143-146. 10.1016/j.chom.2007.08.004, 18005729.
4. Caserta JA, Hale ML, Popoff MR, Stiles BG, McClane BA. Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin. Infection and immunity 2008, 76(12):5677-5685. 10.1128/IAI.00854-08, 2583595, 18809663.
5. Viswanathan VK, Weflen A, Koutsouris A, Roxas JL, Hecht G. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Am J Physiol Gastrointest Liver Physiol 2008, 294(5):G1165-1170. 10.1152/ajpgi.00596.2007, 18356531.
6. Flynn AN, Buret AG. Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability. Microbial pathogenesis 2008, 44(4):311-319. 10.1016/j.micpath.2007.10.007, 18054197.
7. Chen ML, Ge Z, Fox JG, Schauer DB. Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infection and immunity 2006, 74(12):6581-6589. 10.1128/IAI.00958-06, 1698078, 17015453.
8. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. American journal of physiology 2004, 286(6):C1213-1228. 10.1152/ajpcell.00558.2003, 15151915.
9. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-236. 10.1038/nrm1055, 12612641.
10. Furuse M, Hirase T, Itoh M, Nagafuchi A, Honemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993, 123:1777-1788. 10.1083/jcb.123.6.1777, 2290891, 8276896.
11. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE. Occludin is a functional component of the tight junction. J Cell Sci 1996, 109(9):2287-2298.
12. Murata M, Kojima T, Yamamoto T, Go M, Takano K, Osanai M, Chiba H, Sawada N. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res 2005, 310(1):140-151. 10.1016/j.yexcr.2005.07.017, 16112666.
13. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000, 11(12):4131-4142. 15062, 11102513.
14. Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol 2006, 16(4):181-188. 10.1016/j.tcb.2006.02.006, 16537104.
15. Bamforth SD, Kniesel U, Wolburg H, Engelhardt B, Risau W. A dominant negative mutant of occludin disrupts tight junction structure and function. J Cell Science 1999, 112:1879-1888.
16. Blaschuk OW, Oshima T, Gour BJ, Symonds JM, Park JH, Kevil CG, Trocha SD, Michaud S, Okayama N, Elrod JW. Identification of an occludin cell adhesion recognition sequence. Inflammation 2002, 26(4):193-198. 10.1023/A:1016571830091, 12184633.
17. Nusrat A, Brown GT, Tom J, Drake A, Bui TT, Quan C, Mrsny RJ. Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol Biol Cell 2005, 16(4):1725-1734. 10.1091/mbc.E04-06-0465, 1073655, 15659655.
18. Vietor I, Bader T, Paiha K, Huber LA. Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Reports 2001, 2:306-312. 10.1093/embo-reports/kve066, 1083863, 11306551.
19. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 2006, 66(18):9125-9133. 10.1158/0008-5472.CAN-06-1864, 16982755.
20. Yu AL, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Lynch RD, Schneeberger EE. Knock Down of Occludin Expression Leads to Diverse Phenotypic Alterations in Epithelial Cells. Am J Physiol Cell Physiol 2005, 288(6):C1231-1241. 10.1152/ajpcell.00581.2004, 15689410.
21. Potten CS. Epithelial cell growth and differentiation. II. Intestinal apoptosis. Am J Physiol 1997, 273(2 Pt 1):G253-257.
22. Schauser K, Larsson LI. Programmed cell death and cell extrusion in rat duodenum: a study of expression and activation of caspase-3 in relation to C-jun phosphorylation, DNA fragmentation and apoptotic morphology. Histochem Cell Biol 2005, 124(3-4):237-243. 10.1007/s00418-005-0035-7, 16088381.
23. Abreu MT, Palladino AA, Arnold ET, Kwon RS, McRoberts JA. Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells. Gastroenterology 2000, 119(6):1524-1536. 10.1053/gast.2000.20232, 11113074.
24. Monks J, Smith-Steinhart C, Kruk ER, Fadok VA, Henson PM. Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol Reprod 2008, 78(4):586-594. 10.1095/biolreprod.107.065045, 18057312.
25. Watson CJ. Key stages in mammary gland development - Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 2006, 8(2):203. 10.1186/bcr1401, 1557708, 16677411.
26. Rosenblatt J, Raff MC, Cramer LP. An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism. Current Biol 2001, 11:1847-1857.
27. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008, 9(3):231-241. 10.1038/nrm2312, 18073771.
28. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003, 10(1):26-35. 10.1038/sj.cdd.4401186, 12655293.
29. Park SM, Peter ME. MicroRNAs and death receptors. Cytokine Growth Factor Rev 2008, 19(3-4):303-311. 10.1016/j.cytogfr.2008.04.011, 2587095, 18490189.
30. Chung NP, Mruk D, Mo MY, Lee WM, Cheng CY. A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod 2001, 65(5):1340-1351. 10.1095/biolreprod65.5.1340, 11673248.
31. Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 1997, 136(2):399-409. 10.1083/jcb.136.2.399, 2134825, 9015310.
32. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 2000, 97(8):4233-4238. 10.1073/pnas.97.8.4233, 18208, 10760291.
33. Feng W, Wu H, Chan LN, Zhang M. Par-3-mediated junctional localization of the lipid phosphatase PTEN is required for cell polarity establishment. J Biol Chem 2008, 283(34):23440-23449. 10.1074/jbc.M802482200, 18550519.
34. von Stein W, Ramrath A, Grimm A, Muller-Borg M, Wodarz A. Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 2005, 132(7):1675-1686. 10.1242/dev.01720, 15743877.
35. Valiente M, Andres-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 2005, 280(32):28936-28943. 10.1074/jbc.M504761200, 15951562.
36. Peacock JW, Palmer J, Fink D, Ip S, Pietras EM, Mui AL, Chung SW, Gleave ME, Cox ME, Parsons R. PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15. Mol Cell Biol 2009, 29(5):1222-1234. 10.1128/MCB.01660-08, 2643821, 19103758.
37. Bertram J, Peacock JW, Tan C, Mui AL, Chung SW, Gleave ME, Dedhar S, Cox ME, Ong CJ. Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Cancer Res 2006, 66(9):4781-4788. 10.1158/0008-5472.CAN-05-3173, 16651432.
38. Yuan XJ, Whang YE. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 2002, 21(2):319-327. 10.1038/sj.onc.1205054, 11803475.
39. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL. Tight junctions are membrane microdomains. J Cell Sci 2000, 113(Pt 10):1771-1781.
40. Cahuzac N, Baum W, Kirkin V, Conchonaud F, Wawrezinieck L, Marguet D, Janssen O, Zornig M, Hueber AO. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 2006, 107(6):2384-2391. 10.1182/blood-2005-07-2883, 16282344.
41. Neville MC, Stahl L, Brozo LA, Lowe-Lieber J. Morphogenesis and secretory activity of mouse mammary cultures on EHS biomatrix. Protoplasma 1991, 160:110-123.
42. Reichmann E, Ball R, Groner B, Friis RR. New mammary epithelial and fibroblastic cell clones in coculture differentiate functionally. J Cell Biol 1989, 108:1127-1138. 10.1083/jcb.108.3.1127, 2115403, 2466037.
43. Toddywalla VS, Kari FW, Neville MC. Active Transport of nitrofurantoin across a mouse mammary epithelial monolayer. J Pharmacol Exp Therap 1997, 280(2):669-676.
44. Peixoto EB, Collares-Buzato CB. Modulation of the epithelial barrier by dexamethasone and prolactin in cultured Madin-Darby canine kidney (MDCK) cells. Cell Biol Int 2006, 30(2):101-113. 10.1016/j.cellbi.2005.08.004, 16458027.